Abattis Bioceuticals Corp. (ATTBF)

[wingtrade]

Experion Partnership

The issuer’s wholly-owned subsidiary, Northern Vine, completed a share exchange with Experion in April 2014. Pursuant to the transaction, each company received 25% of the issued and outstanding shares of the other company. (The Issuer retains a 75% interest in Northern Vine.) Experion is located in Greater Vancouver and is nearing the completion of its Marijuana for Medical Purposes Regulations (“MMPR”) licence application with Health Canada. It is anticipated that Experion will provide cannabis for Northern Vine’s research and development activities upon receiving its MMPR licence. Experion will also allocate a portion of its 10 acre site for the expansion of Northern Vine’s future processing facility and any expansion requirements needed to satisfy cultivation demand in the foreseeable future. Northern Vine, a lab and compounding pharmacy with patented compositions, owns various Natural Health Product licences for use in the nutraceutical markets. Northern Vine has one outstanding item to complete in order to respond in full to Health Canada’s comments in respect of its controlled substance licence application.

http://www.cnsx.ca/cmsAssets/docs/Filings/2014/2014_05_06_20_36_50_ATT_Form_7.pdf